Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removal

PLoS One. 2006 Dec 20;1(1):e102. doi: 10.1371/journal.pone.0000102.

Abstract

Background: In utero transmission of HIV-1 occurs on average in only 3%-15% of HIV-1-exposed neonates born to mothers not on antiretroviral drug therapy. Thus, despite potential exposure, the majority of infants remain uninfected. Weak HIV-1-specific T-cell responses have been detected in children exposed to HIV-1, and potentially contribute to protection against infection. We, and others, have recently shown that the removal of CD4(+) CD25(+) T-regulatory (Treg) cells can reveal strong HIV-1 specific T-cell responses in some HIV-1 infected adults. Here, we hypothesized that Treg cells could suppress HIV-1-specific immune responses in young children.

Methodology/principal findings: We studied two cohorts of children. The first group included HIV-1-exposed-uninfected (EU) as well as unexposed (UNEX) neonates. The second group comprised HIV-1-infected and HIV-1-EU children. We quantified the frequency of Treg cells, T-cell activation, and cell-mediated immune responses. We detected high levels of CD4(+) CD25(+) CD127(-) Treg cells and low levels of CD4(+) and CD8(+) T cell activation in the cord blood of the EU neonates. We observed HIV-1-specific T cell immune responses in all of the children exposed to the virus. These T-cell responses were not seen in the cord blood of control HIV-1 unexposed neonates. Moreover, the depletion of CD4(+) CD25(+) Treg cells from the cord blood of EU newborns strikingly augmented both CD4(+) and CD8(+) HIV-1-specific immune responses.

Conclusions/significance: This study provides new evidence that EU infants can mount strong HIV-1-specific T cell responses, and that in utero CD4(+) CD25(+) T-regulatory cells may be contributing to the lack of vertical transmission by reducing T cell activation.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • CD4-Positive T-Lymphocytes / immunology
  • CD8-Positive T-Lymphocytes / immunology
  • Cohort Studies
  • Female
  • Fetal Blood / cytology
  • Fetal Blood / immunology
  • HIV Infections / complications*
  • HIV Infections / immunology*
  • HIV Infections / transmission
  • HIV-1 / immunology*
  • Humans
  • Immunity, Cellular
  • Infant
  • Infant, Newborn
  • Infectious Disease Transmission, Vertical
  • Lymphocyte Activation
  • Lymphocyte Depletion
  • Pregnancy
  • Pregnancy Complications, Infectious / immunology*
  • T-Lymphocytes, Regulatory / immunology*
  • gag Gene Products, Human Immunodeficiency Virus / immunology

Substances

  • gag Gene Products, Human Immunodeficiency Virus